Method of producing proteins in filamentous fungi with decreased CLR2 activity
AssigneeBASF SE
InventorsStefan Haefner, Andreas Thywissen, Holger Hartmann, Nico Boehmer
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of producing a recombinant polypeptide a filamentous fungus which is genetically modified to decrease or eliminate the activity of cellulase regulator 2 (CLR2) and to express said recombinant polypeptide. The method further relates to a filamentous fungus Myceliophthora thermophila, which is genetically modified to decrease or eliminate the activity of CLR2 and the use of this filamentous fungus in the production of a recombinant polypeptide.
Claims7
A method of producing a recombinant polypeptide in a filamentous fungus which is genetically modified by disruption of the clr2 gene to decrease or eliminate the activity of cellulase regulator 2 (CLR2) and disruption of the xyr1 gene to decrease or eliminate the activity of xylanase regulator 1 (XYR1) compared to the corresponding filamentous fungus not having the genetic modification which is cultured under the same conditions as the genetically modified filamentous fungus, wherein the filamentous fungus is Myceliophthora thermophila, wherein the filamentous fungus genetically modified to decrease or eliminate the activity of cellulase regulator 2 (CLR2) has been further genetically modified to express said recombinant polypeptide, wherein the recombinant polypeptide is expressed under the control of a promoter which is not activatable by CLR2, wherein the recombinant polypeptide is a polypeptide which is heterologous to the filamentous fungus, wherein the filamentous fungus genetically modified to decrease or eliminate the activity of cellulose regulator 2 (CLR2) has further been genetically modified by disruption of the alp1 gene to decrease or eliminate the activity of alkaline protease 1 (ALP1), said method comprising:
- (i) growing said genetically modified filamentous fungus in a culture medium which does not contain cellulose or any derivative thereof which is capable of inducing CLR2 activity;
- and
- (ii) isolating the recombinant polypeptide from the culture medium.
Dependencies are inferred from the claim text.